Starlight Cardiovascular is developing much needed tools and devices to treat pediatric Congenital Heart Disease (CHD). Approximately 1.3 million babies are born each year with CHD. Most of the tools used to treat these children were designed for adult conditions and anatomy, limiting their utility for pediatric patients. Starlight Cardiovascular is developing a portfolio of devices designed and tested specifically for pediatric CHD with the goals of improving morbidity, mortality, and access to care.